Oragenics, Inc. (OGEN)Healthcare | Biotechnology | Lakewood Ranch, United States | NYSE American
0.72 USD
+0.03
(5.132%)
⇧
(April 17, 2026, 3:57 p.m.
EDT)
After hours: 0.70 -0.01 (-0.012%) ⇩ (April 17, 2026, 7:56 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:19 a.m. EDT
Oragenics (OGEN) remains a high-risk, speculative micro-cap biotech with deteriorating fundamentals, negative cash flow, and no dividend capability. Although recent price action shows a technical recovery from $0.50 lows following a reverse split, the catalyst of a new share offering combined with a heavily negative 45-day forecast (-15.5%) signals severe distribution pressure and neutral-to-negative momentum. As an established long-term hold, the stock suffers from poor profitability metrics and significant equity dilution, making it currently unattractive despite trading below book value. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.180632 |
| AutoETS | 0.284166 |
| AutoARIMA | 0.284169 |
| MSTL | 0.299393 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 69% |
| H-stat | 1.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.384 |
| Excess Kurtosis | -0.74 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.745 |
| Market Cap | 3,100,260 |
| Forward P/E | -0.07 |
| Beta | 1.21 |
| Website | https://www.oragenics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8666667 |
| Address1 | 9,015 Town Center Parkway |
| Address2 | Suite 143 |
| All Time High | 1,620,000.0 |
| All Time Low | 0.5 |
| Ask | 0.77 |
| Ask Size | 300 |
| Average Daily Volume10 Day | 67,350 |
| Average Daily Volume3 Month | 543,027 |
| Average Volume | 543,027 |
| Average Volume10Days | 67,350 |
| Beta | 1.205 |
| Bid | 0.684 |
| Bid Size | 1,400 |
| Book Value | 1.939 |
| City | Lakewood Ranch |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.715 |
| Current Ratio | 5.636 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.7699 |
| Day Low | 0.69 |
| Debt To Equity | 2.745 |
| Display Name | Oragenics |
| Dividend Date | 1,516,579,200 |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,596,800 |
| Ebitda Margins | 0.0 |
| Enterprise Value | -5,072,117 |
| Eps Forward | -10.8 |
| Eps Trailing Twelve Months | -4.56 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.7168 |
| Fifty Day Average Change | -0.0018000007 |
| Fifty Day Average Change Percent | -0.0025111618 |
| Fifty Two Week Change Percent | -86.666664 |
| Fifty Two Week High | 9.6 |
| Fifty Two Week High Change | -8.885 |
| Fifty Two Week High Change Percent | -0.92552084 |
| Fifty Two Week Low | 0.5 |
| Fifty Two Week Low Change | 0.21499997 |
| Fifty Two Week Low Change Percent | 0.42999995 |
| Fifty Two Week Range | 0.5 - 9.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,077,719,400,000 |
| Float Shares | 4,236,604 |
| Forward Eps | -10.8 |
| Forward P E | -0.0662037 |
| Free Cashflow | -5,746,671 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 3 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -2,392,658 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02007 |
| Held Percent Institutions | 0.06617 |
| Implied Shares Outstanding | 4,336,029 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://www.oragenics.com/?q=investors |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,748,908,800 |
| Last Split Factor | 1:30 |
| Long Business Summary | Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida. |
| Long Name | Oragenics, Inc. |
| Market | us_market |
| Market Cap | 3,100,260 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_774436 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -9,842,487 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,100,260 |
| Open | 0.6955 |
| Operating Cashflow | -9,246,387 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Peg Ratio | -8.96 |
| Phone | 813 286 7900 |
| Post Market Change | -0.0123999715 |
| Post Market Change Percent | -1.7342618 |
| Post Market Price | 0.7026 |
| Post Market Time | 1,776,470,195 |
| Previous Close | 0.6801 |
| Price Hint | 4 |
| Price To Book | 0.36874676 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.732 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0349 |
| Regular Market Change Percent | 5.13159 |
| Regular Market Day High | 0.7699 |
| Regular Market Day Low | 0.69 |
| Regular Market Day Range | 0.69 - 0.7699 |
| Regular Market Open | 0.6955 |
| Regular Market Previous Close | 0.6801 |
| Regular Market Price | 0.715 |
| Regular Market Time | 1,776,455,863 |
| Regular Market Volume | 155,692 |
| Return On Assets | -1.0141101 |
| Return On Equity | -2.43942 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,336,029 |
| Shares Percent Shares Out | 0.16610001 |
| Shares Short | 720,353 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 570,220 |
| Short Name | Oragenics Inc. |
| Short Percent Of Float | 0.1663 |
| Short Ratio | 2.81 |
| Source Interval | 15 |
| State | FL |
| Symbol | OGEN |
| Total Cash | 8,399,726 |
| Total Cash Per Share | 1.937 |
| Total Debt | 227,348 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.0229 |
| Two Hundred Day Average Change | -0.3079 |
| Two Hundred Day Average Change Percent | -0.30100694 |
| Type Disp | Equity |
| Volume | 155,692 |
| Website | https://www.oragenics.com |
| Zip | 34,202 |